Long-term results with low glucose degradation product content in peritoneal dialysis fluids

Contributions to Nephrology

Volumn 140, Issue , 2003, Pages 47-55

  Rippe, Bengt ^a   Wieslander, Anders ^b   Musi, Barbara ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Gambro AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42349088242     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071423     Document Type: Article

References (37)

1. Wieslander AP, Nordin MK, Kjellstrand PT, Boberg UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991;40:77-79.
2. Kjellstrand P, Martinson E, Wieslander A, Holmquist B: Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: Influence of time and temperature. Perit Dial Int 1995;15:26-32.
3. Nilsson-Thorell CB, Muscalu N, Andrén AH, Kjellstrand PT, Wieslander AP: Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993;13:208-213.
4. Lindén T, Forsbäck G, Deppisch R, Henle T, Wieslander A: 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998;18:290-293.
5. Lindén T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A: 3,4-Dideoxyglucosone-3-ene: A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002;62:697-703.
6. Barile FA: Introduction to in vitro Cytotoxicology: Mechanisms and Methods. Boca Raton, CRC Press, 1994, pp 27-35.
7. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PT, Boberg UC: Heat-sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993;39:343-348.
8. Wieslander AP, Andren AH, Nilsson-Thorell C, Muscalu N, Kjellstrand PT, Rippe B: Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995;15:348-352.
9. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jörres A: Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739.
10. Dawnay A, Wieslander AP, Millar DJ: Role of glucose degradation products in the generation of characteristic AGE fluorescence in peritoneal dialysis fluid; in O'Brien J, Nursten HE, Crabbe JC, Ames JA (eds): The Maillard Reaction in Foods and Medicine. Proc 6th Int Symp on the Maillard Reaction, London, July 1997. London, The Royal Society of Chemistry, 1997, pp 332-337.
11. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182-186.
12. Jonasson P, Bagge U, Wieslander A, Braide M: Heat-sterilized PD fluid blocks leukocyte adhesion and increases flow velocity in rat peritoneal venules. Perit Dial Int 1996;16(suppl 1):137-140.
13. Musi B, Carlsson O, Rippe A, Wieslander A, Rippe B: Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit Dial Int 1998;18:303-310.
14. Musi B, Braide M, Wieslander A, Rippe A, Albrektsson A, Henle T, Rippe B: Very high daily intraperitoneal doses of carbonyl compounds affect the morphology, but not the exchange characteristics, of rat peritoneum. Blood Purif 2001;19:286-292.
15. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB: Hyperosmolality, acetate and lactate: Dilatory factors during peritoneal dialysis. Kidney Int 1981;20:397-402.
16. Granger DN, Ulrich M, Perry MA, Kvietys PR: Peritoneal dialysis solutions and feline splanchnic blood flow. Clin Exp Pharmacol Physiol 1984;11:473-481.
17. Zakaria ER, Spain DA, Harris PD, Garrison RN: Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions. Perit Dial Int 2002;22:593-601.
18. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH: Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration and glucose degradation products. J Am Soc Nephrol 2002;13:480-489.
19. Rippe B, Simonsen O, Wieslander A, Landgren C: Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1997;17:27-34.
20. Rippe B, Simonsen O, Heimbürger O, Christensson A, Haraldsson B, Stelin G, Weiss L, Nielsen FD, Bro S, Friedberg M, Wieslander A: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001;59:348-357.
21. Lage C, Pischetsrieder M, Aufricht C, Jörres A, Schilling H, Passlick-Deetjen J: First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000;20(suppl 5):28-32.
22. Jones S, Holmes CJ, Krediet RT, Mackenzie R, Faict D, Tranaeus A, Williams JD, Coles GA, Topley N: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 2001;59:1529-1538.
23. Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beelen RH, Krediet RT: Cancer antigen 125: A bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995;10:64-69.
24. Simonsen O, Wieslander A, Landgren C, Rippe B: Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid. Adv Perit Dial 1996;12:156-160.
25. Cappelli G, Bandiani G, Cancarini GC, Feriani M, Dell' Aquila R, Saffioti S, Spisni C, Stingone A, Orazi E, Ballocchi S, Renaux JL: Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: Prospective cross-over study with a three-compartment bag. Adv Perit Dial 1999;15:238-242.
26. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT: Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1997;51:888-893.
27. Rippe B, Krediet RT: Peritoneal physiology. Transport of solutes; in Nolph KD, Gokal RC (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic Publishers, 1994, pp 68-132.
28. Young S, Coles GA, Williams JD, Davies M: The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994;46:527-533.
29. Laurent TC, Laurent UBG, Fraser JRE: The structure and function of hyaluronan: An overview. Immunol Cell Biol 1996;74:A1-A7.
30. Young S, Coles GA, Davies M: IL-lβ, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD. Kidney Int 1996;50:1337-1343.
31. Risteli L: The carboxyterminal propeptide of procollagen type I in serum and biological fluids. Scand J Clin Lab Invest 1990;202:143-146.
32. Graff J, Joffe P, Fugleberg S: Collagen markers in peritoneal dialysis patients. Adv Perit Dial 1995;11:24-27.
33. Inagi R, Miyata T, Yamamoto T, Susuki D, Urakami K, Saito A: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS lett 1999;463:260-264.
34. Krediet RT, Lindholm B, Rippe B: Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000;20(suppl 4):22-42.
35. Mactier RA, Sprosen TS, Gokal R: Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int 1998;53:1061-1067.
36. Tranaeus A: A long-term study of bicarbonate/lactate-based peritoneal dialysis solution - Clinical benefits. The bicarbonate/lactate study group. Perit Dial Int 2000;20:516-523.
37. Zeier M, Schwanger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E: Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 2003;63:298-305.